Kala Pharmaceuticals
在场
Kala Pharmaceuticals 是一家在股票代码 KALA (US) 下上市的公司。
高管
药店
Kala Pharmaceuticals 拥有 1,831 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十二月5号)..
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
药店 行业的其他推荐联系人
消息
Kala Pharmaceuticals 的最新新闻稿
- Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) | Kala Pharmaceuticals, Inc.
- Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) | Kala Pharmaceuticals, Inc.
- Kala Pharmaceuticals to Host Key Opinion Leader Symposium on Unmet Need in Dry Eye Disease and Potential for EYSUVIS™ | Kala Pharmaceuticals, Inc.
- Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September | Kala Pharmaceuticals, Inc.
- Kala Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update | Kala Pharmaceuticals, Inc.
- Kala Pharmaceuticals to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference | Kala Pharmaceuticals, Inc.
- Kala Pharmaceuticals to Report Second Quarter 2020 Financial Results and Host Conference Call | Kala Pharmaceuticals, Inc.
- Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) | Kala Pharmaceuticals, Inc.
- Kala Pharmaceuticals Announces Virtual-Only Format for 2020 Annual Meeting of Stockholders | Kala Pharmaceuticals, Inc.
- Kala Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference | Kala Pharmaceuticals, Inc.
- View more press releases Close
通过电子邮件
